To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...

Scientists at Pohang University of Science and Technology (POSTECH) and ShanghaiTech University have achieved a breakthrough ...

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...

Tsingke has delivered high-quality biotechnology services and products to nearly 300,000 users globally. The number of high-level academic papers published using Tsingke's products and services has ...

The drug redirects the immune system to find and target specific mutations and gene changes that are only found in cancer ...

PLC ("TC BioPharm" or the "Company") , a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced that it has ...

One application is in cell therapy: a patient’s immune cells can be specifically reprogrammed to ... With the new approach, ...

Tsingke has delivered high-quality biotechnology services and products to nearly 300,000 users globally. The number of high-level academic papers published ...

Completed Pre-Biologics License Application (BLA) meeting with the U.S. Food and Drug Administration (FDA) and remain on track to submit a BLA ...

The Company continues to explore systemic priming dosing prior to initiation of intravesical administration, as well as ...